United States · Funded startup

Who invested in Avrobio

2 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$85Mraised across 2 rounds since 2016, from 2 sources

$25MSeries A$60MRound
Latest round
Round, $60MFeb 2018
Step-upi
2.4×
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172018
$25MSeries A$60MRound
First round
Series A, $25M
Aug 2016
Biggest round
$60M
Round · Feb 2018
Between rounds
18 months
from the last two

The rounds

  1. Feb 2018
    Round$60M8 new

    Reported by FinSMEsSEC filing: $60M sold, first sale Jan 2018

  2. Aug 2016
    Series A$25M2 new

    Reported by BusinesswireSEC filing: $7.5M sold, first sale Jul 2016

Founders and team

From the SEC filings it signed: 5 on the team.

  • Christopher MasonExecutive Officeri
  • Deanna PetersenExecutive Officeri
  • Geoffrey MacKayExecutive Officer, Directori
  • Katina DortonExecutive Officeri
  • Kim WarrenExecutive Officeri

On the board, as filediBruce BoothChristopher PaigeIan ClarkJoshua ResnickScott Requadt

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2016Round2018Atlas VentureMorningside GroupCormorant Asset ManagementAtlasBrace PharmaEventideClarusClarus & Life SciencesSurveyor Capital/ AislingSV Health

Everyone who backed them

Atlas VentureVC firm1round
Morningside GroupVC firm1round
Cormorant Asset ManagementPrivate equity1round
AtlasPrivate equity1round
Brace PharmaCompany1round
EventideVC firm1round
Clarusno record of our own yet1round
Clarus & Life Sciencesno record of our own yet1round
Surveyor Capital/ Aislingno record of our own yet1round
SV Healthno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Avrobio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Aisling CapitalPrivate equityPer its own site
Brace PharmaVC firmPer its own site

Quick answers about Avrobio

Who invested in Avrobio?

Avrobio's investors include Atlas Venture, Morningside Group, Cormorant Asset Management, Atlas and Brace Pharma, and 5 more on record.

How much has Avrobio raised?

Avrobio has raised $85M across 2 rounds since 2016.

When did Avrobio last raise?

Avrobio's most recent round was an Undisclosed round of $60M in Feb 2018.

What was Avrobio's biggest round?

Its most recent round, $60M in Feb 2018, is also its largest on record.

Who backed Avrobio first?

Avrobio's first round on record, in Aug 2016, was backed by Atlas Venture and Clarus & Life Sciences.

What stage is Avrobio at?

Avrobio's latest named round is an Undisclosed round, in Feb 2018.

Where is Avrobio based?

Avrobio is based in the United States.

Companies like Avrobio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.